Brain abnormalities seen in children with severe form of diabetes

July 12, 2012 By Jim Dryden
Brain scans identified regions of significantly reduced gray matter (right column) and white matter (left column) in young people with Wolfram syndrome. The brainstem and the cerebellum were particularly affected. (TAMARA HERSHEY, PHD)

(Medical Xpress) -- Children with a rare syndrome that includes a form of insulin-dependent diabetes have brain abnormalities that appear to set the stage for cognitive problems later in life, according to new research at Washington University School of Medicine in St. Louis.

The scientists studied children with Wolfram syndrome, which causes insulin-dependent diabetes in childhood. The disorder also causes hearing and and kidney problems. As patients get older, they can develop and , and more than half die before their 30th birthday.

Earlier case studies had used imaging to identify , but scientists had assumed those changes occurred late in the disease process when Wolfram’s patients got older. The new findings suggest, however, that some changes in the brain occur early in childhood.

The study is published in the online journal Public Library of Science (PLoS) One.

The video will load shortly.

“This work strongly suggests that brain changes occur very early in the disease,” says first author Tamara Hershey, PhD. “The Wolfram gene is important throughout the body — in the heart, retina, pancreas and so on. The pancreas is affected very early in development eventually leading to diabetes, so it stands to reason that other organs like the brain may also be affected at an early age, even before a child experiences any .”

Wolfram syndrome results from mutations in a single gene called WSF-1, which was first identified in 1998 by the late M. Alan Permutt, MD, a former professor of medicine and of cell biology and physiology. He later developed an animal model of the disorder.

In 2010, Permutt organized the world’s first clinic exclusively for patients with Wolfram syndrome. The initiative drew children worldwide to St. Louis for testing and evaluation. Another clinic was held last year, and a third will take place this summer at St. Louis Children’s Hospital.

Hershey, a professor of psychiatry, of neurology and of radiology, focuses on the neurological aspects of Wolfram syndrome. She leads the scientific efforts of the interdisciplinary clinic, along with Bess A. Marshall, MD, associate professor of pediatrics, who is the clinic’s medical director. Nearly a dozen Washington University faculty members evaluate patients at the Wolfram clinic as part of studies to better understand the syndrome.

For the new study, Hershey obtained brain scans of Wolfram patients ages 5-25 and other young patients who only had type 1 diabetes, along with healthy controls in the same age range. The study represents the first time that scientists have attempted to measure and statistically quantify brain differences in patients with Wolfram syndrome.

“These individuals are intact cognitively, and some of them are very smart, high-functioning kids,” she says. “But we have been able to detect significant differences in the size of certain brain structures, leading us to believe that some of these differences must happen during brain development.”

In particular, Hershey’s group has identified changes in the brainstem and the cerebellum. They also found that the skulls of these children tended to be smaller than would have been expected, based on their ages at the time of the study. The investigators also detected differences in the thickness of the brain’s cortex, particularly in parts of the cortex related to vision.

“We were able to pinpoint those regions of the brain that are most affected in terms of size — the brainstem and the cerebellum,” she says. “And we also used a type of imaging called diffusion tensor imaging that allowed us to measure the integrity of white matter pathways in the brain. Again, we found evidence that the brainstem and the cerebellum white matter were affected in patients with Wolfram syndrome, compared to those with type 1 only and healthy controls.”

Wolfram syndrome is very rare, affecting an estimated one in 770,000 children. Before these comprehensive research clinics were established, most of what scientists knew about the brains of patients with the disorder had come from clinical exams of adult patients or autopsies of patients with Wolfram’s.

Hershey believes that by conducting annual MRI scans and continuing to track patients with Wolfram syndrome over time, it may be possible to distinguish changes that occur during development from those that occur due to degeneration related to the disorder.

Explore further: Wolfram Research introduces new programmable document type

More information: Hershey T, Lugar HM, Shimony JS, Rutlin J, Koller JM, Perantie DC, Paciorkowski AR, Eisenstein SA, Permutt MA. Early brain vulnerability in Wolfram Syndrome. PLoS One, July 11, 2012. dx.plos.org/10.1371/journal.pone.0040604.

Related Stories

Wolfram Research introduces new programmable document type

July 25, 2011
(PhysOrg.com) -- Wolfram Research, the same folks who brought us both Mathematica, and Wolfram Alpha (see here, here, and here), the search computation site, is now announcing via Conrad Wolfram’s blog, that it has designed ...

Falls may be early sign of Alzheimer's

July 18, 2011
Falls and balance problems may be early indicators of Alzheimer’s disease, researchers at Washington University School of Medicine in St. Louis report July 17, 2011, at the Alzheimer’s Association International ...

Children with fetal alcohol spectrum disorders have less deep-gray brain matter

May 19, 2011
Children and youth who have fetal alcohol spectrum disorders have less deep-gray matter in their brains compared to children who don’t have the condition, according to a collaborative study by a multidisciplinary team ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.